Neovasc Inc
NVCN
Get informed when a big investor buys or sells
+ FollowMarket Cap$82.86M
Close$
$50.49
68.1% upside
Current Fair Value
68.1% upsideUndervalued by 68.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $82.86 Million |
|---|---|
| Enterprise Value | $82.86 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-15.07 |
| Beta | 2.01 |
| Outstanding Shares | 2,734,013 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -1.99 |
|---|---|
| PEG | -1.59 |
| Price to Sales | 30.03 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 21.78 |
| Enterprise Value to EBIT | -2.46 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Neovasc Inc
71 employees
CEO: Fred Colen Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is not current...